Johnson & Johnson Q4 Earnings Beat, But Stock Falls on Stelara
Johnson & Johnson reports Q4 earnings of $2.46/share, beating estimates with 9.1% sales growth to $24.6B, but stock falls 3% on Stelara patent loss concerns.
NOTRELOAD AI
Citi Turns Bullish on Abercrombie & Fitch After Stock Pullback
Citi upgrades Abercrombie & Fitch to Buy, raising its price target to $135 and highlighting strong growth and cash flow potential in 2026.
Arm Stock Gets a Boost as Analysts See Opportunity After Selloff
Susquehanna upgrades Arm to Positive, citing AI and data center growth as key long-term drivers despite recent stock weakness.
PDD Holdings Faces Minor Tax Fine: Citi Sees Relief for Investors
PDD Holdings fined $14K by Shanghai tax authorities for delayed compliance. Citi analysts view penalty as "smaller-than-feared," maintaining Buy rating with stock jumping 4% premarket.
Lisata Therapeutics Acquired by Kuva Labs for $4/Share
Kuva Labs to acquire Lisata at $4/share plus $2 in contingent payments—an 85% premium. Deal expected to close before Feb 27, 2026.
Smithfield Foods Snaps Up Nathan's Famous Hot Dogs for $450M
Smithfield Foods acquires iconic Nathan's Famous hot dog brand for $450 million, securing perpetual rights to grow the beloved all-beef frankfurter business.